AbbVie Inc. balance sheet
At the end of its fiscal year on Dec 31, 2025, AbbVie Inc. reported total assets of $133.96B and shareholders' equity of −$3.27B. That works out to a current ratio of 0.67 (current assets ÷ current liabilities). Equity is negative, which typically reflects accumulated buybacks or losses exceeding contributed capital; see the filing for details.
Balance sheet at each fiscal year end
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $66.10B | $70.79B | $59.35B | $89.11B | $150.56B | $146.53B | $138.81B | $134.71B | $135.16B | $133.96B |
| Current assets | $16.19B | $21.22B | $16.95B | $49.52B | $24.17B | $27.93B | $28.46B | $33.00B | $25.58B | $29.06B |
| Cash & equivalents | $5.10B | $9.30B | $7.29B | $39.92B | $8.45B | $9.75B | $9.20B | $12.81B | $5.52B | $5.23B |
| Current liabilities | $9.78B | $16.64B | $17.24B | $15.59B | $28.66B | $35.19B | $29.54B | $37.84B | $38.75B | $43.29B |
| Long-term debt | — | — | — | $67.23B | $84.95B | $75.96B | $63.13B | $59.24B | $66.84B | $64.50B |
| Shareholders' equity | $4.64B | $5.10B | −$8.45B | −$8.17B | $13.08B | $15.41B | $17.25B | $10.36B | $3.33B | −$3.27B |
| Reported in | 10-K 2018 | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 |
Balance-sheet figures are point-in-time values on the last day of each fiscal year. Some companies (for example banks and insurers) do not present current assets and liabilities; those cells show —.
Source: SEC EDGAR XBRL company facts for CIK 1551152 (raw data). Most recent filing in this dataset: 10-Q filed Nov 3, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.